Sandbox:Mehrian: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
The hallmarks of 17OHD, first described in 1966 [3], include hypertension and hypokalemia due to the accumulation of cortisol precursors with mineralocorticoid activity upstream of the block, plus sexual infantilism due to inability to synthesize androgens and estrogens. Unlike most other forms of CAH, mineralocorticoid excess and high corticosterone production [9] mitigate the clinical consequences of cortisol deficiency, and symptomatic adrenal insufficiency is rare [4,10-16].
==Pathogenesis==
CYP17A1 metabolizes pregnenolone, progesterone, and their 17-hydroxy derivatives early in the steroidogenic cascades (figure 2) [11]. Consequently, 17OHD eliminates the synthesis of most steroids and limits steroidogenesis to progesterone, 11-deoxycoricosterone (DOC), corticosterone, and 18-oxygenated derivatives (table 1) [12,13]. DOC binds with high affinity to the mineralocorticoid receptor and is not a substrate for 11-beta hydroxysteroid dehydrogenase type 2. DOC excess causes volume expansion, hypertension, and kaluresis despite suppressed renin and aldosterone production.
* 17 alpha-hydroxylase deficiency results in a decreased synthesis of both [[cortisol]] and [[sex steroid]]s, in addition to an increase in [[mineralocorticoid]] production. Hypertension and hypokalemia occur due to the accumulation of cortisol precursors with mineralocorticoid activity upstream of the block, plus sexual infantilism due to inability to synthesize androgens and estrogens. Unlike most other forms of CAH, mineralocorticoid excess and high corticosterone production [9] mitigate the clinical consequences of cortisol deficiency, and symptomatic adrenal insufficiency is rare
The lack of 17,20-lyase activity precludes conversion of 21-carbon steroids to 19-carbon androgen precursors in both 17OHD and ILD (figure 2). In ILD, 17-hydroxyation is largely preserved, and DOC does not accumulate, hence hypertension and hypokalemia are not found. Low 19-carbon steroid production, however, causes variable degrees of genital ambiguity in affected 46,XY males with a tendency for gynecomastia during puberty, as occurs in many states of low testosterone synthesis. Affected girls develop only sparse pubic hair and can have dysmenorrhea [14].
* This form of congenital adrenal hyperplasia results from deficiency of the [[enzyme]] [[17α-hydroxylase]] (also called [[CYP17A1]]).<ref name="w">Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency. Wikipedia (2016. https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency  Accessed on February 4, 2016</ref>
Clinical presentation — The classic presentation of severe 17OHD in phenotypic females (who can have 46,XX or 46,XY karyotypes) includes [3,9,10]:
* 17α-hydroxylase deficiency impairs the efficiency of [[cortisol]] synthesis, resulting in high levels of [[adrenocorticotropic hormone]] secretion and hyperplasia of the adrenal glands.  
* Clinical effects of this condition include overproduction of [[mineralocorticoid]]s and deficiency of prenatal and [[puberty|pubertal]] [[sex steroid]]s. CYP17A1 functions in [[steroidogenesis]], where it converts [[pregnenolone]] and [[progesterone]] to their 17-hydroxy forms. The enzyme itself is attached to the smooth [[endoplasmic reticulum]] of the steroid-producing cells of the [[adrenal gland|adrenal cortex]] and [[gonad]]s. CYP17A1 functions as both a 17α-hydroxylase and a 17,20-lyase. The dual activities mediate three key transformations in [[cortisol]] and [[sex steroid]] synthesis:
Hypertension
* As 17α-hydroxylase it mediates [[pregnenolone]] → [[17-hydroxypregnenolone]] and [[progesterone]] → [[17-hydroxyprogesterone]].
* As 17,20-lyase it mediates 17-hydroxypregnenolone → [[DHEA|Dehydroepiandrosterone]].
Primary amenorrhea
* An expected second 17,20-lyase reaction (17-hydroxyprogesterone → [[androstenedione]]) is mediated so inefficiently in humans as to be of no known significance.
* The hydroxylase reactions are part of the synthetic pathway to cortisol as well as sex steroids, but the lyase reaction is only necessary for sex steroid synthesis.
Absence of secondary sexual characteristics
* The dual enzyme activities were for many decades assumed to represent two entirely different genes and enzymes: 7α-hydroxylase deficient congenital adrenal hyperplasia, and a distinct and even rarer defect of sex steroid synthesis termed 17,20-lyase deficiency. In the last decade, it has become clear that the two diseases are different forms of defects of the same gene. However, the clinical features of the two types of impairment are distinct enough that they are described separately in the following sections.
===Mineralocorticoid Effects===
Minimal body hair
* The adrenal cortex is hyperplastic and overstimulated, with no impairment of the mineralocorticoid pathway. Consequently, levels of deoxycorticosterone, [[corticosterone]], and 18-deoxycorticosterone are elevated. Although these precursors of [[aldosterone]] are weaker mineralocorticoids, the extreme elevations usually provide enough volume expansion, blood pressure elevation, and potassium depletion to suppress [[renin]] and aldosterone production. Some persons with 17α-hydroxylase deficiency develop [[hypertension]] in infancy, and nearly 90% do so by late childhood. The low-renin [[hypertension]] is often accompanied by [[hypokalemia]] due to urinary potassium wasting and [[metabolic alkalosis]]. These features of mineralocorticoid excess are the major clinical clue distinguishing the more complete 17α-hydroxylase deficiency from the 17,20-lyase deficiency, which only affects the sex steroids. Treatment with glucocorticoid suppresses ACTH, returns mineralocorticoid production toward normal, and lowers blood pressure.
[[Image:Steroidogenesis.png|thumb|center|800px|Production of DHEA from Cholesterol. ([[Cortisol]] is a [[glucocorticoid]].)]]
===Glucocorticoid Effects===
* Although production of cortisol is inefficient enough to normalize ACTH, the 50-100-fold elevations of [[corticosterone]] have enough weak [[glucocorticoid]] activity to prevent glucocorticoid deficiency and adrenal crisis.
===Sex Steroid Effects===
* Genetic XX females affected by 17α-hydroxylase deficiency are born with normal female internal and external anatomy. At the expected time of [[puberty]], neither the adrenals nor the ovaries can produce sex steroids, so neither breast development nor pubic hair appears. Investigation of delayed puberty yields elevated [[gonadotropin]]s and normal karyotype while imaging confirms the presence of ovaries and an infantile uterus. Discovery of hypertension and hypokalemic [[alkalosis]] usually suggests the presence of one of the proximal forms of congenital adrenal hyperplasia, and the characteristic mineralocorticoid elevations confirm the specific diagnosis.
* A few milder forms of this deficiency in genetic females have allowed relatively normal breast development and irregular menstruation. Evidence suggests that only 5% of normal enzyme activity may be enough to allow at least the physical changes of female puberty, if not [[ovulation]] and fertility. In these girls, the elevated blood pressure was the primary clinical problem.
* 17α-Hydroxylase deficiency in genetic males (XY) results in moderate to severe reduction of fetal [[testosterone]] production by both adrenals and testes. [[virilization|Undervirilization]] is variable and sometimes complete. The appearance of the external [[genitalia]] ranges from normal female to ambiguous to mildly underdeveloped male. The most commonly described phenotype is a small [[phallus]], [[perineum|perineal]] [[hypospadias]], small blind pseudovaginal pouch, and intra-abdominal or [[inguinal canal|inguinal]] testes. [[Wolffian duct]] derivatives are hypoplastic or normal, depending on the degree of testosterone deficiency. Some of those with partial virilization develop [[gynecomastia]] at puberty even though masculinization is reduced. The presence of hypertension in the majority distinguishes them from other forms of partial androgen deficiency or [[androgen insensitivity syndrome|insensitivity]]. Fertility is impaired in those with more than minimal testosterone deficiency.

Revision as of 19:38, 3 August 2017

Pathogenesis

  • 17 alpha-hydroxylase deficiency results in a decreased synthesis of both cortisol and sex steroids, in addition to an increase in mineralocorticoid production. Hypertension and hypokalemia occur due to the accumulation of cortisol precursors with mineralocorticoid activity upstream of the block, plus sexual infantilism due to inability to synthesize androgens and estrogens. Unlike most other forms of CAH, mineralocorticoid excess and high corticosterone production [9] mitigate the clinical consequences of cortisol deficiency, and symptomatic adrenal insufficiency is rare
  • This form of congenital adrenal hyperplasia results from deficiency of the enzyme 17α-hydroxylase (also called CYP17A1).[1]
  • 17α-hydroxylase deficiency impairs the efficiency of cortisol synthesis, resulting in high levels of adrenocorticotropic hormone secretion and hyperplasia of the adrenal glands.
  • Clinical effects of this condition include overproduction of mineralocorticoids and deficiency of prenatal and pubertal sex steroids. CYP17A1 functions in steroidogenesis, where it converts pregnenolone and progesterone to their 17-hydroxy forms. The enzyme itself is attached to the smooth endoplasmic reticulum of the steroid-producing cells of the adrenal cortex and gonads. CYP17A1 functions as both a 17α-hydroxylase and a 17,20-lyase. The dual activities mediate three key transformations in cortisol and sex steroid synthesis:
  • As 17α-hydroxylase it mediates pregnenolone17-hydroxypregnenolone and progesterone17-hydroxyprogesterone.
  • As 17,20-lyase it mediates 17-hydroxypregnenolone → Dehydroepiandrosterone.
  • An expected second 17,20-lyase reaction (17-hydroxyprogesterone → androstenedione) is mediated so inefficiently in humans as to be of no known significance.
  • The hydroxylase reactions are part of the synthetic pathway to cortisol as well as sex steroids, but the lyase reaction is only necessary for sex steroid synthesis.
  • The dual enzyme activities were for many decades assumed to represent two entirely different genes and enzymes: 7α-hydroxylase deficient congenital adrenal hyperplasia, and a distinct and even rarer defect of sex steroid synthesis termed 17,20-lyase deficiency. In the last decade, it has become clear that the two diseases are different forms of defects of the same gene. However, the clinical features of the two types of impairment are distinct enough that they are described separately in the following sections.

Mineralocorticoid Effects

  • The adrenal cortex is hyperplastic and overstimulated, with no impairment of the mineralocorticoid pathway. Consequently, levels of deoxycorticosterone, corticosterone, and 18-deoxycorticosterone are elevated. Although these precursors of aldosterone are weaker mineralocorticoids, the extreme elevations usually provide enough volume expansion, blood pressure elevation, and potassium depletion to suppress renin and aldosterone production. Some persons with 17α-hydroxylase deficiency develop hypertension in infancy, and nearly 90% do so by late childhood. The low-renin hypertension is often accompanied by hypokalemia due to urinary potassium wasting and metabolic alkalosis. These features of mineralocorticoid excess are the major clinical clue distinguishing the more complete 17α-hydroxylase deficiency from the 17,20-lyase deficiency, which only affects the sex steroids. Treatment with glucocorticoid suppresses ACTH, returns mineralocorticoid production toward normal, and lowers blood pressure.
Production of DHEA from Cholesterol. (Cortisol is a glucocorticoid.)

Glucocorticoid Effects

  • Although production of cortisol is inefficient enough to normalize ACTH, the 50-100-fold elevations of corticosterone have enough weak glucocorticoid activity to prevent glucocorticoid deficiency and adrenal crisis.

Sex Steroid Effects

  • Genetic XX females affected by 17α-hydroxylase deficiency are born with normal female internal and external anatomy. At the expected time of puberty, neither the adrenals nor the ovaries can produce sex steroids, so neither breast development nor pubic hair appears. Investigation of delayed puberty yields elevated gonadotropins and normal karyotype while imaging confirms the presence of ovaries and an infantile uterus. Discovery of hypertension and hypokalemic alkalosis usually suggests the presence of one of the proximal forms of congenital adrenal hyperplasia, and the characteristic mineralocorticoid elevations confirm the specific diagnosis.
  • A few milder forms of this deficiency in genetic females have allowed relatively normal breast development and irregular menstruation. Evidence suggests that only 5% of normal enzyme activity may be enough to allow at least the physical changes of female puberty, if not ovulation and fertility. In these girls, the elevated blood pressure was the primary clinical problem.
  • 17α-Hydroxylase deficiency in genetic males (XY) results in moderate to severe reduction of fetal testosterone production by both adrenals and testes. Undervirilization is variable and sometimes complete. The appearance of the external genitalia ranges from normal female to ambiguous to mildly underdeveloped male. The most commonly described phenotype is a small phallus, perineal hypospadias, small blind pseudovaginal pouch, and intra-abdominal or inguinal testes. Wolffian duct derivatives are hypoplastic or normal, depending on the degree of testosterone deficiency. Some of those with partial virilization develop gynecomastia at puberty even though masculinization is reduced. The presence of hypertension in the majority distinguishes them from other forms of partial androgen deficiency or insensitivity. Fertility is impaired in those with more than minimal testosterone deficiency.
  1. Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency. Wikipedia (2016. https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency Accessed on February 4, 2016